Year-end report 1 January – 31 December 2024

AddLife finishes the year with high growth, improved margins, and strong cash flow


  
AddLife finishes 2024 with a very strong fourth quarter. Organic growth was 9%, EBITA increased by 24%, and cash flow improved by 49%. The companies within AddLife performed very well, driven by positive demand development and dedicated, long-term efficiency efforts.  
   

Fredrik Dalborg, President and CEO 

1 OCTOBER– 31 DECEMBER 2024 (3 MONTHS)

  • Net sales increased by 11% to SEK 2,818m (2,544). The organic growth, excluding exchange rate changes, was 9% and the acquired growth was 1%. 
  • EBITA increased by 24% to SEK 346m (278), corresponding to an EBITA-margin of 12.3% (10.9). The EBITA margin for the previous year was 10.2%, adjusted for reversed contingent considerations and one-off costs. 
  • Profit after tax amounted to SEK 94m (-41).
  • Earnings per share amounted to SEK 0.76 (-0.34).
  • Cash flow from operating activities amounted to SEK 666m (448).

 

1 JANUARY – 31 DECEMBER 2024 (12 MONTHS)

  • Net sales increased by 6% to SEK 10,286m (9,685). The organic growth, excluding exchange rate changes, was 5%. 
  • EBITA increased by 2% to SEK 1,159m (1,135), corresponding to an EBITA-margin of 11.3% (11.7). Adjusted for revalued contingent considerations and restructuring costs, EBITA amounted to SEK 1,165m (1,015). Excluding these, EBITA increased by 14% and the EBITA-margin amounted to 11.3% (10.5).
  • Profit after tax amounted to SEK 254m (192).
  • Earnings per share amounted to SEK 2.06 (1.56).
  • Cash flow from operating activities amounted to SEK 1,095m (773).
  • The equity ratio was 41% (39).
  • Return on working capital (P/WC) amounted to 51% (50).
  • During the financial year an acquisition, BonsaiLab SLU, was completed. The acquisition is estimated to contribute with an annual net sale of approximately SEK 90m.
  • The board proposes a dividend of SEK 0.75 per share.
  3 months ending 12 months ending
SEKm 31 Dec 24 31 Dec 23 31 Dec 24 31 Dec 23
Net sales 2,818 2,544 10,286 9,685
EBITA 346 278 1,159 1,135
EBITA-margin 12.3% 10.9% 11.3% 11.7%
Profit before tax 150 2 405 339
Profit for the period 94 -41 254 192
Earnings per share before dilution, SEK 0.76 -0.34 2.06 1.56
Earnings per share after dilution, SEK 0.76 -0.34 2.06 1.56
Dynamisk graf: Net sales (SEKm)
Dynamisk graf: EBITA (SEKm)
  3 months ending 12 months ending
One-off costs, SEKm 31 Dec 24 31 Dec 23 31 Dec 24 31 Dec 23
Restructuring reserve AddVision – -8 – -8
Restructuring reserve Camanio – – -10 –
Write-down tangible assets Camanio Health – -19 – -19
Revalued contingent consideration 0 46 4 147
Total one-off costs, EBITA 0 19 -6 120
Write-down intangible assets Camanio Care – -106 – -106
Total one-off costs, EBIT 0 -87 -6 14
         
  3 months ending 12 months ending
Classification in income statement, SEKm 31 Dec 24 31 Dec 23 31 Dec 24 31 Dec 23
Cost of sales – -1 – -1
Selling expenses – -54 -2 -54
Administrative expenses – -8 -3 -8
Research and Development – -70 -5 -70
Other operating income and expenses 0 46 4 147
Total one-off costs in the income statement 0 -87 -6 14
Latest updated: 2/4/2025 4:08:56 PM by jamilah.wass@add.life
NEXT